PROM1 and breast cancer: As a number of studies in Atypical Theratoid/Rabdoid Tumor (AT/RT) and breast cancer have shown, DSF with the addition of Cu++ reduced the expression of cancer stem-like cells (CSCs) by decreasing levels of ALDH, CD133 and Nestin, three markers of CSCs in brain malignancies [13, 19].